Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

792 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Recruiting

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT07759245

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • NewportNativeMD, Inc. Newport Beach, California, United States
  • Institute of HealthCare Assessment d/b/a Apex Clinical Research San Diego, California, United States
  • National Jewish Health Medical Center Denver, Colorado, United States
View all 127 locations
View Trial Details
Recruiting

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

NCT07780656

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Tampa, Florida, United States
  • GSK Investigational Site Rapid City, South Dakota, United States
  • GSK Investigational Site West Point, Utah, United States
View Trial Details
Recruiting

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

NCT07177339

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Doral, Florida, United States
  • GSK Investigational Site Chengdu, China
  • GSK Investigational Site Guilin, China
  • GSK Investigational Site Jiangmen, China
View all 121 locations
View Trial Details
Recruiting

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

NCT06959095

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Loxahatchee Groves, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Rock Hill, South Carolina, United States
  • GSK Investigational Site Corsicana, Texas, United States
View all 15 locations
View Trial Details

Related conditions